Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (<35 years, 35 years, >35 years): Forecast to 2022 By Type - Pap Test, HPV Test, Colposcopy and Cervical Biopsies. By Age Group Below 35 years and 35 years and above. By Region- North America, Europe, Asia Pacific, and ROW. By Country - U.S, Canada, Germany, U.K, China, India, Mexico and Brazil. January 2018
Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (<35 years, 35 years, >35 years): Forecast to 2022 g Scope of the Study Global Coverage Regional Coverage Country Coverage Segment Coverage By Type By Age Group Region (North America, Europe, APAC and ROW) Country (U.S., Canada, Brazil, Mexico, Germany, U.K, China, and India) Global Coverage Regional Coverage Country Coverage Company Coverage Global Cervical Cancer Diagnostics Market By Value (2012-16) Global Cervical Cancer Diagnostics Market By Value (2017-22) Global Cervical Cancer Diagnostics Market Breakdown- By Type, By Value Pap Test HPV Test Colposcopy Cervical Biopsies Global Cervical Cancer Diagnostics Market Breakdown-By Age Group, By Value Below 35 years 35 years and above North America Europe Asia Pacific ROW Cervical Cancer Diagnostics Market, (2012-2016) Cervical Cancer Diagnostics Market, (2017-2022) By Value By Type, By Value By Age Group, By Value U.S. Canada Mexico Brazil Germany U.K China India Cervical Cancer Diagnostics Market (2012-2022) By Value By Type, By Value By Age Group, By Value Hologic, Inc. Abott Laboratories Roche Diagnostics Guided Therapeutics Becton, Dickinson and Company Qiagen Quest Diagnostics Arbor Vita Corporation Product Benchmarking Sales* Business Overview Recent Product Approvals Merger & Acquisition *for listed companies only. 2
Table of Content S.No Particulars Page No. 1. Research Methodology 20 2. Executive Summary 21 3. Strategic Recommendation 22 3.1 Increasing demand for HPV tests in global cervical cancer diagnostics market. 23 3.2 Asia Pacific Region to witness the fastest growth in cervical cancer diagnostics market in the forecast period. 24 4. Cervical Cancer Outlook 25 5. Global Cervical Cancer Diagnostics Market: Growth and Forecast 38 5.1 By Value (2012-2016) 39 5.2 By Value (2017-2022) 40 6. Global Cervical Cancer Diagnostics Market Segmental Analysis 47 3
Table of Content S.No Particulars Page No. 6.1 Global Cervical Cancer Diagnostics Market Size, By Type: Breakdown (%) 47 6.1.1 Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%) 49 6.1.2 Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%) 50 6.1.3 Global Pap Test Market, By Value (2012-2022) 51 6.1.4 Global HPV Test Market, By Value (2012-2022) 52 6.1.5 Global Colposcopy Market, By Value (2012-2022) 53 6.1.6 Global Cervical Biopsies Market, By Value (2012-2022) 54 6.2 Global Cervical Cancer Diagnostics Market Size, By Age Group, Breakdown (%) 55 6.2.1 Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%) 56 6.2.2 Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%) 57 4
Table of Content S.No Particulars Page No. 6.2.3 6.2.4 Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value (2012-2022) Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value (2012-2022) 58 59 7. Global Cervical Cancer Diagnostics Market: Regional Analysis 60 7.1 Global Cervical Cancer Diagnostics Market Size, By Region: Breakdown (%) 60 7.1.1 Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%) 61 7.1.2 Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%) 62 7.2 North America Cervical Cancer Diagnostics Market: Growth and Forecast 63 7.2.1 By Value (2012-2016) 64 7.2.2 By Value (2017-2022) 65 7.2.3 By Type, By Value (2012-2022) 71 5
Table of Content S.No Particulars Page No. 7.2.4 By Age Group, By Value (2012-2022) 72 7.3 North America Cervical Cancer Diagnostics Market: Country Analysis (U.S and Canada) 73 7.3.1 U.S Cervical Cancer Diagnostics Market, By Value (2012-2022) 75 7.3.2 U.S Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 77 7.3.3 U.S Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 78 7.3.4 Canada Cervical Cancer Diagnostics Market, By Value (2012-2022) 80 7.3.5 Canada Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 81 7.3.6 Canada Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 82 7.4 Europe Cervical Cancer Diagnostics Market: Growth and Forecast 85 7.4.1 By Value (2012-2016) 86 6
Table of Content S.No Particulars Page No. 7.4.2 By Value (2017-2022) 87 7.4.3 By Type, By Value (2012-2022) 94 7.4.4 By Age Group, By Value (2012-2022) 95 7.5 Europe Cervical Cancer Diagnostics Market: Country Analysis (Germany and U.K) 96 7.5.1 Germany Cervical Cancer Diagnostics Market, By Value (2012-2022) 98 7.5.2 Germany Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 99 7.5.3 Germany Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 100 7.5.4 U.K Cervical Cancer Diagnostics Market, By Value (2012-2022) 102 7.5.5 U.K Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 103 7.5.6 U.K Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 104 7
Table of Content S.No Particulars Page No. 7.6 APAC Cervical Cancer Diagnostics Market: Growth and Forecast 106 7.6.1 By Value (2012-2016) 107 7.6.2 By Value (2017-2022) 108 7.6.3 By Type, By Value (2012-2022) 114 7.6.4 By Age Group, By Value (2012-2022) 115 7.7 APAC Cervical Cancer Diagnostics Market: Country Analysis (China and India) 116 7.7.1 China Cervical Cancer Diagnostics Market, By Value (2012-2022) 118 7.7.2 China Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 119 7.7.3 China Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 120 7.7.4 India Cervical Cancer Diagnostics Market, By Value (2012-2022) 122 8
Table of Content S.No Particulars Page No. 7.7.5 India Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 123 7.7.6 India Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 124 7.8 ROW Cervical Cancer Diagnostics Market: Growth and Forecast 126 7.8.1 By Value (2012-2016) 127 7.8.2 By Value (2017-2022) 127 7.8.3 By Type, By Value (2012-2022) 129 7.8.4 By Age Group, By Value (2012-2022) 130 7.9 ROW Cervical Cancer Diagnostics Market: Country Analysis (Brazil and Mexico) 131 7.9.1 Brazil Cervical Cancer Diagnostics Market, By Value (2012-2022) 133 7.9.2 Brazil Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 135 9
Table of Content S.No Particulars Page No. 7.9.3 Brazil Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 136 7.9.4 Mexico Cervical Cancer Diagnostics Market, By Value (2012-2022) 138 7.9.5 Mexico Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022) 140 7.9.6 Mexico Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022) 141 8. Global Cervical Cancer Diagnostics Market Dynamics 143 8.1 Global Cervical Cancer Diagnostics Market Drivers 144 8.2 Global Cervical Cancer Diagnostics Market Restraints 148 9. Global Cervical Cancer Diagnostics Market Trends 150 10. Porter Five Force Analysis 153 11. SWOT Analysis 155 10
Table of Content S.No Particulars Page No. 12. Supply Chain Analysis 157 13. Pricing Analysis 159 14. Competitive Landscape: 164 14.1 Company Share Analysis of Key Industry Players 165 14.2 Product Benchmarking of Key Industry Players 167 14.3 Recent Product Approvals of Key Industry Players 169 15. Policy and Regulatory Landscape 170 16. Company Profiling 175 16.1 Hologic 176 16.2 Abott Laboratories 178 11
Table of Content S.No Particulars Page No. 16.3 Roche 181 16.4 Guided Therapeutics 183 16.5 Becton, Dickinson and Company 185 16.6 Qiagen 187 16.7 Quest Diagnostics 189 16.8 Arbor Vita Corporation 191 17. About Us 192 12
List of Figures Figure No. Figure Title Page No. Figure 1: Global Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 39 Figure 2: Global Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million) 40 Figure 3: Healthcare Costs Per Capita, By Select Countries, 2015 (USD) 41 Figure 4: World Female Population Estimates, 2017 (In Millions) 43 Figure 5: Age-Standardized Cervical Cancer Incidence Rate (per 100,000 women per year), By Region 43 Figure 6: Top 10 Most Frequent Cancer in Females, World, (Age standardised incidence rate per 100,000 women) 44 Figure 7: Top 10 Most Frequent Cancer Deaths in Females, World, (Age standardised incidence rate per 100,000 women) 44 Figure 8: Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%) 49 Figure 9: Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%) 50 Figure 10: Global PAP Test Market, By Value, 2012-2016 (USD Million) 51 Figure 11: Global PAP Test Market, By Value, 2012-2016 (USD Million) 51 Figure 12: Global HPV Test Market, By Value, 2012-2016 (USD Million) 52 Figure 13: Global HPV Test Market, By Value, Forecast, 2017-2022 (USD Million) 52 Figure 14: Global Colposcopy Test Market, By Value, 2012-2016 (USD Million) 53 Figure 15: Global Colposcopy Test Market, By Value, Forecast, 2017-2022 (USD Million) 53 Figure 16: Global Cervical Biopsies Market, By Value, 2012-2016 (USD Million) 54 Figure 17: Global Cervical Biopsies Market, By Value, Forecast, 2017-2022, (USD Million) 54 Figure 18: Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%) 56 Figure 19: Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%) 57 13
List of Figures Figure No. Figure Title Page No. Figure 20: Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, 2012-2016 (USD Million) 58 Figure 21: Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, Forecast, 2017-2022 (USD Million) 58 Figure 22: Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, 2012-2016 (USD Million) Figure 23: Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, Forecast, 2017-2022 (USD Million) Figure 24: Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%) 61 Figure 25: Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%) 62 Figure 26: North America Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 64 Figure 27: North America Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million) 65 Figure 28: North America Healthcare Cost Per Capita, By Select Country, 2016 (USD) 66 Figure 29: North America GDP, 2012-2015 (USD Trillion) 66 Figure 30: North America GDP, By Select Country, 2016 (USD Trillion) 66 Figure 31: United States of America, Per Capita Expenditure on Healthcare, 2012-2016 (USD) 67 Figure 32: Canada, Per Capita Expenditure on Healthcare, 2012-2016 (USD) 67 Figure 33: United States of America, Female Population in the age group 15-64, 2012-2016 68 Figure 34: Canada, Female Population in the age group 15-64, 2012-2016 68 Figure 35: North America Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 71 Figure 36: North America Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 72 Figure 37: U.S. Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 75 Figure 38: U.S Health Spending, By Service or Product, 2016 (%) 76 Figure 39: U.S Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 77 59 59 14
List of Figures Figure No. Figure Title Page No. Figure 40: U.S Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 78 Figure 41: Canada Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 80 Figure 42: Canada Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 81 Figure 43: Canada Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 82 Figure 44: North America Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total) 84 Figure 45: North America Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 84 Figure 46: North America Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 86 Figure 47: Europe Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million) 87 Figure 48: Europe, GDP, By Select Country, 2016, (USD Billion) 89 Figure 49: Europe Health Spending Per Capita, By Select Country, 2016 (USD) 89 Figure 50: United Kingdom, Per Capita Expenditure on Healthcare, 2012-2016 (USD) 90 Figure 51: Germany, Per Capita Expenditure on Healthcare, 2012-2016 (USD) 90 Figure 52: United Kingdom, Female Population in the age group 15-64, 2012-2016 91 Figure 53: Germany, Female Population in the age group 15-64, 2012-2016 91 Figure 54: Europe Medical Technology Market Based on Manufacturer Prices, By Country, 2016 (%) 92 Figure 55: Europe Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 94 Figure 56: Europe Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 95 Figure 57: Germany Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 98 Figure 58: Germany Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 99 Figure 59: Germany Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 100 Figure 60: U.K Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 102 15
List of Figures Figure No. Figure Title Page No. Figure 61: U.K Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 103 Figure 62: U.K Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 104 Figure 63: Europe Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total) 105 Figure 64: Europe Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 105 Figure 65: APAC Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 107 Figure 66: APAC Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million) 108 Figure 67: APAC, GDP, By Select Country, 2016, (USD Billion) 110 Figure 68: APAC Health Expenditure Per Capita, Public and Private, By Select Country, 2016 (USD) 110 Figure 69: China, Female Population in the age group 15-64, 2012-2016 111 Figure 70: India, Female Population in the age group 15-64, 2012-2016 111 Figure 71: India, Degree of Urbanization, 2012-2016 (in %) 112 Figure 72: China, Degree of Urbanization, 2012-2016, (in %) 112 Figure 73: APAC Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 114 Figure 74: APAC Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 115 Figure 75: China Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 118 Figure 76: China Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 119 Figure 77: China Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 120 Figure 78: China Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 122 Figure 79: India Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 123 Figure 80: India Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 124 16
List of Figures Figure No. Figure Title Page No. Figure 81: APAC Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total) 125 Figure 82: APAC Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 125 Figure 83: ROW Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 127 Figure 84: ROW Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) 129 Figure 85: ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 130 Figure 86: ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 133 Figure 87: Brazil, Female Population in the age group 15-64, 2012-2016 134 Figure 88: Brazil, Degree of Urbanization, 2012-2016 (in %) 134 Figure 89: Brazil Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 135 Figure 90: Brazil Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 136 Figure 91: Mexico Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million) 138 Figure 92: Mexico, Female Population in the age group 15-64, 2012-2016 139 Figure 93: Mexico, Degree of Urbanization, 2012-2016 (in %) 139 Figure 94: Mexico Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) 140 Figure 95: Mexico Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) 141 Figure 96: ROW Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total) 142 Figure 97: ROW Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total) 142 Figure 98: Global Cervical Cancer Diagnostics Market, By Company Share, 2016 (%) 165 Figure 99: Hologic, Revenue, 2013-2017 (USD Billion) 177 Figure 100: Hologic, Revenue, By Geography, 2017 (%) 177 17
List of Figures Figure No. Figure Title Page No. Figure 101: Hologic, Revenue, By Segment, 2017 (%) 177 Figure 102: Abbott Laboratories, Revenue, 2012-2016 (USD Million) 179 Figure 103: Abobott Laboratories, Revenue, By Segment, 2016 (%) 179 Figure 104: Abbott, Revenue, By Geography, 2016 (%) 180 Figure 105: Roche, Revenue, 2012-2016 (USD Million) 182 Figure 106: Roche, Revenue, By Segment, 2016 (%) 182 Figure 107: Roche, Revenue, By Geography, 2016 (%) 182 Figure 108: Guided Therapeutics, Sales, 2012-2016 (USD thousands) 184 Figure 109: BD, Revenue, 2012-2016 (USD Million) 186 Figure 110: BD, Revenue, By Geography, 2017 (%) 186 Figure 111: BD, Revenue, By Segment, 2017 (%) 186 Figure 112: Qiagen, Revenue, 2012-2016 (USD Millions) 188 Figure 113: Qiagen, Revenue, By Geography, 2016 (%) 188 Figure 114: Qiagen, Revenue, By Product Categories, 2016 (%) 188 Figure 115: Quest Diagnostics, Revenue, 2012-2016 (USD Millions) 190 Figure 116: Quest Diagnostics, Revenue, By Business Segments, 2016 (%) 190 18
List of Tables Table No. Table Title Page No. Table A: List of Abbreviations 26 Table B: Cervical Cancer Flowchart 34 Table C: Cervical Cancer Screening Recommendations 35 Table D: Cervical Cancer Diagnostics Segmentation Flowchart 37 Table E: Medical Tourism Market Drivers 42 Table F: Medical Tourism Index, By Region and Top Destinations 42 Table G: Recent Company Acquisitions in Cervical Cancer Diagnostics Market 46 Table H: HPV-Associated and HPV-Attributable Cancer Statistics, U.S, 2015 69 Table I: Major Players in cervical cancer diagnostics market in North America 83 Table J: Europe, Female Population aged 15+, By Region, 2017, (In Millions) 88 Table K: Major Players in cervical cancer diagnostics market in Europe 92 Table L: Pricing Analysis of PAP TEST 160 Table M: Pricing Analysis of HPV TEST 161 Table N: Pricing Analysis of Colposcopy Test 162 Table O: Pricing Analysis of Colposcopy Test 163 Table P: Roche, Growth Strategy 166 Table Q: Product Benchmarking of Key Industry Players, By Type 167 Table R: Product Benchmarking of Key Industry Players, By Type 168 Table S: Product Benchmarking of Key Industry Players, By Type 169 19
Research Methodology For our study on Global Cervical Cancer Diagnostics Market, we have conducted comprehensive secondary research followed by an extensive primary research. In the process of secondary research, we have scrutinized industry documents, accessed from open sources, premium paid databases and our internal knowledge base. In the process of primary research, we have interviewed various industry experts across the value chain of the medical equipment and service industry. Market size of the actual period (2012-2016) has been evaluated on the basis of growth trends of the industry in the last five years, and confirming the findings through primary research. Annual reports of the companies are scanned to further validate the market size and to estimate the size of various other applications. Market sizing and growth in the forecast period (2017-2022) is estimated through revenue mapping, growth of new advance equipment and technology and historical growth pattern of the industry. All the relevant data points/ statistics in the forecast period are validated through relevant and reliable primary sources. Report Focus: Global Cervical Cancer Diagnostics Market. - By Type (Pap Test, HPV Test, Colposcopy and Cervical Biopsies) - By Age Group ( Below 35 years and 35 years and above) - By Region (North America, Europe, Asia Pacific and ROW), - By Country (U.S., Canada, Brazil, Mexico, Germany, U.K, China and India) - Company Coverage (Roche, Hologic, Abott Laboratories, Guided Therapeutics, Qiagen, etc.) Companies Contacted: Qiagen, Recombigen Laboratories (c) AZOTH Analytics 20
Global Cervical Cancer Diagnostics Market Overview Growing healthcare awareness in addition to increased expenditure in healthcare sector has been boosting the global cervical cancer diagnostics market. Figure : Global Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million) CAGR 2012-2016 xxxx% 2012 2013 2014 2015 2016 Source: Azoth Analytics Estimates xxxx Xxxx Xxxx Xxxx xxxx 21
Global Colposcopy Test Market Global Low Temperature Sterilization Market, By Value Figure : Global Colposcopy Test Market, By Value, 2012-2016 (USD Million) CAGR 2012-2016 xxxx% Figure : Global Colposcopy Test Market, By Value, Forecast, 2017-2022 (USD Million) CAGR 2017-2022 xxxx% 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Source: Azoth Analytics Estimates Xxxx Xxxx Xxxx Xxxx xxxx xxxxx 22
Global Cervical Cancer Diagnostics Market- By Age Group Female population aged 35 years and above held the major market share of approximately 74.44% in the year 2016. Key Drivers Figure : Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%) Xxxx xxxx Below 35 years Xxxx 35 years and above xxxx Xxxx Source: Azoth Analytics Estimates xxxx 23
U.K Cervical Cancer Diagnostics Market, By Type Figure : U.K Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million) CAGR 2012-2016 Pap Test : xx% HPV Test : xx% Colposcopy : xx% Cervical Biopsies : xx% CAGR 2017-2022 Pap Test : xx% HPV Test : xx% Colposcopy : xx% Cervical Biopsies : xx% 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Pap Test HPV Test Colposcopy Cervical Biopsies 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Pap Test HPV Test Colposcopy Cervical Biopsies Xxxx xxxx Source: Azoth Analytics Estimates 24
ROW Cervical Cancer Diagnostics Market, By Age Group Figure : ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million) CAGR 2012-2016 Below 35 years : xx% 35 years and above : xx% CAGR 2017-2022 Below 35 years : xx% 35 years and above : xx% 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Below 35 years 35 years and above 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Below 35 years 35 years and above Xxxx Xxxx xxxx Source: Azoth Analytics Estimates 25
About Azoth Analytics Pvt Ltd. Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food & beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts). Related Reports: Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021)-(By Type: Imaging Tests, Endoscopy, Biopsy, Tumor Marker; By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography; By Region: North America, Latin America, APAC, Europe, MEA) 26